Home › Soft Tissue Sarcoma › Texas › San Antonio
Soft Tissue Sarcoma clinical trials in San Antonio, TX
4 studies for Soft Tissue Sarcoma are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Oncology, San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Audie L Murphy VA Hospital, San Antonio
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RecruitingPhase 1/2
- NEXT Oncology, San Antonio
- The START Center, San Antonio
IDOV-Immune for Advanced Solid Tumors
RecruitingPhase 1
- South Texas Accelerated Research Therapeutics, San Antonio
About Soft Tissue Sarcoma
Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available
More about Soft Tissue Sarcoma on MedlinePlus
Soft Tissue Sarcoma trials in other cities
- Houston, TX32 studies
- New York City, NY20 studies
- Boston, MA18 studies
- St. Louis, MO14 studies
- Los Angeles, CA13 studies
- Columbus, OH13 studies
- Washington, DC12 studies
- Memphis, TN11 studies
- Philadelphia, PA10 studies
- Queens, NY9 studies
- Rochester, MN9 studies
- Aurora, CO9 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Breast Cancer46 studies
- Colorectal Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity39 studies
- Type 2 Diabetes36 studies
- Overweight33 studies
- Pancreatic Cancer31 studies
- Ovarian Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.